Evidence suggests that anger and pain are related, yet it is not clear by what mechanisms anger may influence pain. We have proposed that effects of anger states and traits on pain sensitivity are partly opioid mediated. In this study, we test the extent to which analgesic effects of acute anger arousal on subsequent pain sensitivity are opioid mediated by subjecting healthy participants to anger-induction and pain either under opioid blockade (oral naltrexone) or placebo. Participants were 160 healthy individuals. A double-blind, placebo-controlled, between-subjects opioid blockade design is used, with participants assigned randomly to one of two drug conditions (placebo or naltrexone), and to one of two Task Orders (anger-induction followed by pain or vice versa). Results of ANOVAs show significant Drug Condition Â Task Order interactions for sensory pain ratings (MPQ-Sensory) and angry and nervous affect during pain-induction, such that participants who underwent anger-induction prior to pain while under opioid blockade (naltrexone) reported more pain, and anger and nervousness than those who underwent the tasks in the same order, but did so on placebo. Results suggest that for people with intact opioid systems, acute anger arousal may trigger endogenous opioid release that reduces subsequent responsiveness to pain. Conversely, impaired endogenous opioid function, such as that found among some chronic pain patients, may leave certain people without optimal buffering from the otherwise hyperalgesic affects of anger arousal, and so may lead to greater pain and suffering following upsetting or angry events. Ó
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Introduction
Anger states and traits appear to affect pain sensitivity. Associations between anger and pain have been reported in studies of acute pain induced in the laboratory [9,13,14,16,25], and evidence suggests that anger variables can exacerbate the severity of chronic pain [8,13,27,43]. Recently, models have been proposed to explain how anger variables may influence pain (e.g., [12] ).
One model focuses on whether endogenous opioid functioning may underlie the connection between anger variables and pain sensitivity [9] . Findings regarding the role of negative affect in endogenous opioid-mediated analgesia provide indirect support. Frew and Drummond [23] reported that in healthy women, discouragement induced by a mental arithmetic task performed under threat of electric shock was associated with endogenous opioid release that tempered the otherwise hyperalgesic effects of this negative affect. Related work in depressed patients similarly indicated that increased depression induced by stressful mental arithmetic was associated with opioid release that reduced subsequent pain responsiveness [24] . Other results suggest that acute anger arousal may have similar analgesic effects. Subjects undergoing a computer tracking task with experimenter harassment reported greater increases in anger than subjects not experiencing harassment, and also displayed significant increases in subsequent pain tolerance compared to nonharassed subjects [25] . These effects are consistent with those anticipated if anger arousal triggered opioid release producing subsequent analgesia, although the design of this study did not test specifically for opioid mechanisms.
More directly, findings indicate that pharmacological blockade of endogenous opioids produces increased anger, suggesting an association specifically between anger and opioids, although the absence of an experimental anger manipulation in this work limits the conclusions that can be drawn [28, 32] . Findings of brain imaging studies are also relevant, suggesting that endogenous opioid activity in the orbitofrontal cortex, rostral anterior cingulate cortex, amygdala, insula, and periaqueductal gray regions contribute to modulation of both pain and negative affects, including anger [5, 6, 34, 40, 44, 45, 46] . Taken together, findings support the hypothe-
